Imexpharm Corp
VN:IMP
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| VN |
I
|
Imexpharm Corp
VN:IMP
|
8.6T VND |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
923.3B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
582.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
257.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.9B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.8B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.7B USD |
Loading...
|
Market Distribution
| Min | -10 851.5% |
| 30th Percentile | 2% |
| Median | 5.3% |
| 70th Percentile | 11.3% |
| Max | 318.1% |
Other Profitability Ratios
Imexpharm Corp
Glance View
Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Imexpharm Corp is 18.9%, which is above its 3-year median of 17.6%.
Over the last 3 years, Imexpharm Corp’s Operating Margin has increased from 16.8% to 18.9%. During this period, it reached a low of 15.5% on Sep 30, 2024 and a high of 18.9% on Jan 1, 2026.
